<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02319863</url>
  </required_header>
  <id_info>
    <org_study_id>Chenxp5</org_study_id>
    <secondary_id>2012ZX10002016-004</secondary_id>
    <nct_id>NCT02319863</nct_id>
  </id_info>
  <brief_title>Rapid Ligating the Corresponding Inflow and Outflow Vessels Without Hilus Dissection During Hepatectomy</brief_title>
  <official_title>A Simple Technique of Rapid Ligating the Corresponding Inflow and Outflow Vessels Without Hilus Dissection During Hepatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huazhong University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huazhong University of Science and Technology</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study examines the role of this simple technique on postoperative metastasis and long
      term survival.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The only hope of long-term survival for patients with primary hepatocellular carcinoma (HCC)
      is surgical resection or liver transplantation, the former of which is more feasible at
      present. However, postoperative recurrence or metastasis is an ominous feature for this
      disease. Innovation of the surgical procedure for improving prognosis is under emergency
      request. This study examines the role of this simple technique on postoperative metastasis
      and long term survival.

      During the past 20 years, more 600 patients with primary HCC were performed hepatectomy with
      the new hemorrhage control technique, and prospective randomized controlled trial (RCT) was
      applied. We further applied a mice model ligating the pedicle of the lesion-located hepatic
      lobe before hepatectomy to imitate the clinic practice, and evaluated the role of the new
      technique on postoperative metastasis and survival.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 1994</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>recurrence</measure>
    <time_frame>12 months</time_frame>
    <description>to examine if there is intrahepatic recurrence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>metastasis</measure>
    <time_frame>12 months</time_frame>
    <description>to examine if there is intrahepatic metastasis and metastasis in distant organs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>1 month</time_frame>
    <description>intraoperative death， and death in one month after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prognosis</measure>
    <time_frame>5 years</time_frame>
    <description>to check the 5 years overall survival (OS) and disease free survival (DFS)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Cancer Progression</condition>
  <arm_group>
    <arm_group_label>conventional resection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Perform hepatectomy with conventional method for HCC patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>new method</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The new technique of rapid ligating the corresponding inflow and outflow vessels without hills dissection before parenchyma transection during hepatectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>hepatectomy (conventional method)</intervention_name>
    <description>A Simple Technique of Rapid Ligating the Corresponding Inflow and Outflow Vessels Without Hilus Dissection During Hepatectomy</description>
    <arm_group_label>conventional resection</arm_group_label>
    <other_name>liver resection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>hepatectomy (rapid ligating)</intervention_name>
    <arm_group_label>new method</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HCC patients who will perform left- or right- hemihepatectomy.

        Exclusion Criteria:

          1. contraindication for hepatectomy, including gastrointestinal hemorrhage, severe
             hemorrhagic disorders, explicit acute nonspecific infectious lesion, overt ascites,
             Child-Pugh Score C,indocyanine green retention rate at 15min (ICGR15)＞30%,serum
             hepatitis B virus (HBV)-DNA＞106 copies/ml and serum alanine aminotransferase
             (ALT)＞2×ULN, serum triglycerides＞2.0 mmol/L, circulatory shock, stroke, acute
             myocardial infarction, renal failure, coma of unknown cause;

          2. pregnancy;

          3. age of＜18y or＞65y
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaoping Chen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tongji Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaoping Chen, M.D.</last_name>
    <phone>+86 27 83662851</phone>
    <email>chenxp@medmail.com.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Binhao Zhang, M.D.</last_name>
    <phone>+86 15802726021</phone>
    <email>bhzhang8@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tongji Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoping Chen, M.D.</last_name>
      <phone>+86 27 83662851</phone>
      <email>chenxp@medmail.com.cn</email>
    </contact>
    <contact_backup>
      <last_name>Binhao Zhang, M.D.</last_name>
      <phone>+86 15802726021</phone>
      <email>bhzhang8@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Chen XP, Qiu FZ. A simple technique ligating the corresponding inflow and outflow vessels during anatomical left hepatectomy. Langenbecks Arch Surg. 2008 Mar;393(2):227-30; discussion 231-4. Epub 2007 Nov 3.</citation>
    <PMID>17978838</PMID>
  </reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 11, 2014</study_first_submitted>
  <study_first_submitted_qc>December 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2014</study_first_posted>
  <last_update_submitted>December 15, 2014</last_update_submitted>
  <last_update_submitted_qc>December 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 18, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Huazhong University of Science and Technology</investigator_affiliation>
    <investigator_full_name>Xiaoping Chen</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>hepatocellular carcinoma</keyword>
  <keyword>prognosis</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

